Stocksigma LogoStocksigma Logo

India Glycols Demerger Creates Three Entities Amid Strong Specialty Chemicals Margin Expansion

India Glycols Limited executed a strategic demerger effective 1st Sep'26, creating three independent listed entities: IGL Spirits (67% FY26 net revenue

India Glycols Demerger Creates Three Entities Amid Strong Specialty Chemicals Margin Expansion

India Glycols Ltd 路 Investor Presentation 路 03 Sept 2026, 3:01 am

India Glycols Demerger Creates Three Entities Amid Strong Specialty Chemicals Margin Expansion India Glycols Limited executed a strategic demerger effective 1st Sep'26, creating three independent listed entities: IGL Spirits (67% FY26 net revenue share), retained IGL (28%), and Ennature Biopharma (6%). The retained IGL business, focused on bio-based specialty chemicals, reported FY26 net sales of INR 1,164 Cr. Despite revenue moderation, adjusted EBITDA reached INR 330 Cr, driving a robust margin expansion to 28.4%. Looking ahead, management targets INR 2,000 Cr net revenue and INR 400 Cr EBITDA over the next 4-5 years, driven by specialty-led portfolio development.

Original exchange filing (PDF)

More announcements from India Glycols Ltd

All India Glycols Ltd announcements